Program
Scientific Program
- May 14 (Thu)
- 09:00-11:30
- Year in Review
- Room 1 (3F)
- KOR (ENG Translation)
- Chairs
- Geun Tae Kim (Kosin Univ., Korea)
- Bo Young Yoon (Inje Univ., Korea)
09:00-09:30
Emerging Treatments in Rheumatoid Arthritis
09:30-10:00
Psoriatic Arthritis
10:00-10:30
Recent Advances in Lupus Nephritis: A Year in Review
10:30-11:00
Sjögren's Disease
11:00-11:30
ANCA-Associated Vasculitis
- May 14 (Thu)
- 12:00-13:00
- Luncheon Symposium 1 [Celltrion]
- Efficacy of Infliximab SC in Treatment of axSpA
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
12:00-13:00
From Clinical Trials to Real-World Evidence: The Totality of Evidence for Subcutaneous Infliximab
- May 14 (Thu)
- 13:00-14:30
- Presidential Plenary Session
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
13:00-13:40
A Life So Good, Unique
13:40-14:20
Charting a Path to Research Excellence in Rheumatology
- May 14 (Thu)
- 15:30-17:00
- International Joint Symposium (KCR and APLAR member)
- Room 1 (3F)
- ENG
- Chairs
- Kichul Shin (Seoul Nat'l Univ., Korea)
- Lai-Shan Tam (The Chinese Univ. of Hong Kong, Hong Kong)
15:30-15:50
Prevention of Bone Damage in Psoriatic Arthritis
15:50-16:10
Driving Quality Care in RA in the APLAR Region: Leveraging Registry Data from Patients and Clinicians
16:10-16:30
State-of-the-Art Systemic Lupus Erythematosus
16:30-16:50
Social Justice and Rheumatology
- May 14 (Thu)
- 17:00-18:00
- Evening Symposium 1 [Novartis]
- Transforming Lives: Breakthrough Innovations in Autoimmune Disease
- Room 1 (3F)
- ENG
- Chair
- Kyung-Su Park (The Catholic Univ. of Korea, Korea)
17:00-18:00
Unlocking Sjögren’s Disease: Advances and Updates in SJD Management
- May 14 (Thu)
- 12:00-13:00
- Luncheon Symposium 2 [Samsung Bioepis]
- Spondyloarthritis
- Room 2 (3F)
- ENG
- Chair
- Bin Yoo (Univ. of Ulsan, Korea)
12:00-13:00
The Evolving Landscape of axSpA Treatment: Real-World Insights from the European Experience
- May 14 (Thu)
- 13:00-14:30
- Free Paper Session 1_Systemic Lupus Erythematosus (SLE)
- Room 2 (3F)
- ENG
- Chairs
- Hye-Soon Lee (Hanyang Univ., Korea)
- Chang-Hee Suh (Ajou Univ., Korea)
13:00-13:10
(2026-0043) Mendelian Randomization and Transcriptomics Reveal That RNASET2 Dysfunction in Immune Cells Increases the Risk of Systemic Lupus Erythematosus
13:10-13:20
(2026-0332) Accumulation of Terminally Exhausted T-cells in the Kidneys of MRL/lpr Mice Is Correlates with Serum Levels of Interferon-γ-Inducible Protein 10
13:20-13:30
(2026-0118) 3H-1,2-Dithiole-3-Thione Modulates Pathogenic B Cell Responses and Ameliorates Lupus Nephritis in C57BL/6 Lpr Mice
13:30-13:40
(2026-0111) Therapeutic Potential of Immunoregulatory Gut Microbiota and Fecal Metabolites in Preclinical Models of Lupus
13:40-13:50
(2026-0376) Dysregulation of Sphingosine-1-phosphate Signaling in Systemic Lupus Erythematosus and Its Therapeutic Implications
13:50-14:00
(2026-0155) A Patient-derived Humanized Mouse Avatar Platform for Monitoring Disease Activity and Personalized Drug Screening in Systemic Lupus Erythematosus
14:00-14:10
(2026-0046) A Study on a Computational Fluid Dynamics-based Model of Systemic Lupus Erythematosus Vasculitis
14:10-14:20
(2026-0181) Real-world Outcomes of Belimumab or Calcineurin Inhibitor Add-on Therapy to Mycophenolate in Lupus Nephritis
14:20-14:30
(2026-0109) Serum IL-32γ as a Biomarker for Remission Assessment in Systemic Lupus Erythematosus
- May 14 (Thu)
- 15:30-17:00
- Free Paper Session 2_SLE & Antiphospholipid Syndrome and Sjögren's Syndrome
- Room 2 (3F)
- ENG
- Chairs
- Young Ho Lee (Korea Univ., Korea)
- Seung-Ki Kwok (The Catholic Univ. of Korea, Korea)
15:30-15:40
(2026-0414) Histological Evolution and Clinical Impact of Repeat Renal Biopsy in Lupus Nephritis
15:40-15:50
(2026-0172) Association between Antiphospholipid Antibodies and Subclinical Carotid Atherosclerosis in Systemic Lupus Erythematosus: A Cohort-based Study
15:50-16:00
(2026-0243) Differences between the 2006 Revised Sapporo Classification Criteria and 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome: A Multicenter Validation Study
16:00-16:10
(2026-0150) S100A4 and S100A7 as Markers of Immune Activation in Sjögren’s Syndrome
16:10-16:20
(2026-0246) Dissecting the Immune Genetic Architecture of Sjögren’s Syndrome Using a Single-cell Causal Framework
16:20-16:30
(2026-0107) Clinical Characteristics of Sjögren’s Disease Patients Presenting with Glandular Swelling at Diagnosis: A Single-center Cohort Study
16:30-16:40
(2026-0121) Time-dependent Progression of Salivary Gland Ultrasound Abnormalities in Sjögren’s Disease: A Longitudinal Single-center Prospective Cohort Study
16:40-16:50
(2026-0356) Patient-reported Experiences and Disease Burden of Sjögren’s Disease in Korea: A Nationwide Multicenter Survey Adapted from the Sjögren’s Foundation Questionnaire (PRESS Study)
16:50-17:00
(2026-0439) Nine-year Longitudinal Changes in Salivary Gland Ultrasonography in Primary Sjögren’s Disease
- May 14 (Thu)
- 17:00-18:00
- Evening Symposium 2 [Johnson&Johnson]
- SIMPONI SC Efficacy in AS
- Room 2 (3F)
- ENG
- Chair
- Seong-Ho Kim (Inje Univ., Korea)
17:00-18:00
Improving Treatment Persistence with Golimumab: Low Immunogenicity and Management of Extra-musculoskeletal Manifestations
- May 14 (Thu)
- 12:00-13:00
- Luncheon Symposium 3 [GSK]
- Shingles Prevention as a Priority in Rheumatology
- Room 3 (5F)
- ENG
- Chair
- Eun Bong Lee (Seoul Nat'l Univ., Korea)
12:00-13:00
Timings and Targets in Vaccine-Preventable Diseases: Shingles Prevention in Rheumatology
- May 14 (Thu)
- 13:00-14:30
- Free Paper Session 3_Systemic Sclerosis and Vasculitis
- Room 3 (5F)
- ENG
- Chairs
- Chan-Bum Choi (Hanyang Univ., Korea)
- Hyun-Sook Kim (Soonchunhyang Univ., )
13:00-13:10
(2026-0235) Obacunone Modulates GPX4-associated Ferroptosis and Attenuates Skin Fibrosis in Bleomycin-induced Systemic Sclerosis Model
13:10-13:20
(2026-0193) Dual Therapeutic Potential of FTY720 in Systemic Sclerosis: Modulation of Pathogenic Th2/Th17 Responses and Enrichment of Beneficial Gut Microbiota
13:20-13:30
(2026-0157) Targeted Immunotherapy for Systemic Sclerosis: CNP-D/R/V Nano-vaccine Reverses Fibrosis by Modulating the Th17/Treg Balance in an Antigen-specific Manner
13:30-13:40
(2026-0371) GSDMD mRNA and Serum IL-1βas Potential Biomarkers for Early-stage Systemic Sclerosis: Correlation with Scl-70 Subtype and Organ Damage
13:40-13:50
(2026-0274) Deep Learning Framework for the Diagnosis of Systemic Sclerosis Using Serum-derived Microbial Signatures
13:50-14:00
(2026-0080) Clinical Characteristics and Factors Associated with Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis-associated Interstitial Lung Disease
14:00-14:10
(2026-0103) Rapamycin Inhibits the Polarisation of CD4+ T Cells towards TH1 Cells in Patients with Active Granulomatosis with Polyan-giitis and Microscopic Polyangiitis
14:10-14:20
(2026-0211) Large-vessel FDG Uptake on PET/CT in Patients with ANCA-associated Vasculitis: Implications for Classification and Interpretation
14:20-14:30
(2026-0209) Peripheral Arterial Assessment as a Complementary Tool in the Evaluation of Cutaneous Arteritis
- May 14 (Thu)
- 15:30-17:00
- Free Paper Session 4_Myositis and Metabolic Bone Diseases
- Room 3 (5F)
- ENG
- Chairs
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- Jinhyun Kim (Chungnam Nat'l Univ., Korea)
15:30-15:40
(2026-0349) Bioinformatics-inferred Autoantibody-linked Tissue-specific Plasma Proteomic Endotypes in New-onset Juvenile Dermatomyositis Predict Persistent Disease Activity and Endothelial Vasculopathy Risk Using Longitudinal Pediatric Cohort
15:40-15:50
(2026-0337) Untargeted Metabolomic Profiling Identified Increased Kynurenine-related Pathway in Idiopathic Inflammatory Myopathy
15:50-16:00
(2026-0296) PEX5 Acts as a Negative Regulator of RANKL-induced Osteoclastogenesis in Vitro and Inflammatory Calvarial Bone Destruction in Vivo
16:00-16:10
(2026-0228) The Essential Role of Osteoclast-derived DPP4 in Bone Regeneration and Fracture Healing
16:10-16:20
(2026-0221) Calcium Carbonate or Sodium Bicarbonate Combination Prevent Esomeprazole-induced Osteoporosis in Rat
16:20-16:30
(2026-0087) The Association between Abdominal Muscle Mass and Osteoporosis in Postmenopausal Women
16:30-16:40
(2026-0094) Effect of Janus Kinase Inhibitors on Bone Mineral Density in Rheumatoid Arthritis Patients with Osteoporosis: A Comparative Study with Biologics Therapy
16:40-16:50
(2026-0068) Long Term Outcomes of Kudo Type Total Elbow Arthroplasty in Rheumatoid Arthritis
- May 14 (Thu)
- 14:30-15:30
- Poster Viewing & Tour 1
- Poster Zone (5F)
- ENG
- May 14 (Thu)
- 17:00-17:40
- Building the KCR Rheumatoid Arthritis Fact Sheet: A Collaborative Initiative with NHIS
- Room 3 (5F)
- KOR (ENG Translation)
- Chairs
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- Jaiyong Kim (Director, Department of Big Data Management, NHIS, Korea)
17:00-17:10
Presentation 1: Overview of the KCR Rheumatoid Arthritis Fact Sheet Initiative
17:10-17:25
Presentation 2: How to Conduct Clinical Epidemiology Research with National Health Insurance Data
17:25-17:40
Presentation 3: Rheumatoid Arthritis Fact Sheet Results I: Incidence, Prevalence, and Beyond
- May 15 (Fri)
- 08:00-09:00
- Breakfast Symposium 1 [Samsung Bioepis]
- Osteoporosis
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Gwan Gyu Song (Korea Univ., Korea)
08:00-09:00
Optimizing Fracture Prevention in Rheumatic Patients: Updates on High-Risk Management Strategies
- May 15 (Fri)
- 09:00-10:00
- Keynote Lecture 1
- Room 1 (3F)
- ENG
- Chair
- Yong-Beom Park (Yonsei Univ., Korea)
09:00-10:00
Central Role for EBV in Systemic Lupus Erythematosus
- May 15 (Fri)
- 10:30-12:00
- International Symposium 1_Mastering the Spondyloarthritis Spectrum
- Room 1 (3F)
- ENG
- Chairs
- Tae-Hwan Kim (Hanyang Univ., Korea)
- Tae-Jong Kim (Chonnam Nat'l Univ., Korea)
10:30-11:00
Past, Present, and New Horizons in Spondyloarthritis Research
11:00-11:30
Long-Term Prognosis and Outcomes from Cohort Data
11:30-12:00
Clinical Trial and Real-World Data for Optimal Treatment Decisions
- May 15 (Fri)
- 12:00-13:00
- Luncheon Symposium 4 [Abbvie]
- Exploring Disease Control Strategies of JAK inhibitor for Rheumatoid Arthritis
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Sang-Cheol Bae (Hanyang Univ., Korea)
12:00-13:00
Optimizing Treatment for Early Remission in Rheumatoid Arthritis with Upadacitinib
- May 15 (Fri)
- 13:00-14:30
- International Symposium 2_KCR-GOUT/G-CAN Joint Symposium
- Room 1 (3F)
- ENG
- Chairs
- Jung Soo Song (Chung-Ang Univ., Korea)
- Seung-Jae Hong (Kyung Hee Univ., Korea)
13:00-13:30
Gout 2026: New Biology, New Therapies
13:30-14:00
Emerging Urate-Lowering Drugs and Their Application to Gout Treatment Strategies
14:00-14:30
Beyond Crystal Deposition: Gouty Tophi as Structured Inflammatory Microenvironments
- May 15 (Fri)
- 15:30-17:00
- International Symposium 3_Contemporary Understanding and Innovative Treatments for Fibromyalgia
- Room 1 (3F)
- ENG
- Chairs
- Hyun Ah Kim (Hallym Univ., Korea)
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
15:30-16:00
Distinguishing Inflammatory and Nociplastic Pain: Clinical Implications for Fibromyalgia and Inflammatory Arthritis
16:00-16:30
EULAR Perspectives on Fibromyalgia: From Pathophysiology to Updated Management Recommendations
16:30-17:00
Is Fibromyalgia an Autoimmune Disease? Rethinking the Evidence
- May 15 (Fri)
- 08:00-09:00
- Breakfast Symposium 2 [Pfizer & Hanlim MS]
- The Role of Xeljanz
- Room 2 (3F)
- KOR (ENG Translation)
- Chair
- Jae-Bum Jun (Hanyang Univ., Korea)
08:00-09:00
As First Approved JAK, Broaden Indications, and Over 10-Year Experience in Korea
- May 15 (Fri)
- 10:30-12:00
- Free Paper Session 5_Osteoarthritis and Pain in Rheumatic Diseases
- Room 2 (3F)
- ENG
- Chairs
- Hyun Sik Gong (Seoul Nat'l Univ., Korea)
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
10:30-10:40
(2026-0170) Kindlin-2 Alleviates Osteoarthritis by Regulating Mitochondrial STAT3 Function and Suppressing Inflammatory Cell Death through Mitochondrial Translocation
10:40-10:50
(2026-0189) Mito-metformin Ameliorates Osteoarthritis Progression by Restoring Mitochondrial Function and Modulating Chondrocyte Inflammation and Cell Death
10:50-11:00
(2026-0051) Intra-articular Delivery of Sox9 mRNA-lipid Nanoparticles Attenuates Osteoarthritis by Enhancing Ciliary Function and Suppressing Wnt Signaling
11:00-11:10
(2026-0085) Lubricating MXenzyme Hydrogel Microspheres Orchestrate Innate and Adaptive Immune Modulation for Osteoarthritis Therapy
11:10-11:20
(2026-0342) Epigallocatechin Gallate Based pH-Sensitive PEGylated Liposomes Ameliorate Monoiodoacetate-induced Osteoarthritis in Rats via Alteration of HO-1/Nrf2, PI3K/Akt and MAPK Signaling Pathways
11:20-11:30
(2026-0230) Topological Analysis of Subchondral Bone Density in Trapeziometacarpal and Scaphotrapezial Arthritis Using Three-dimensional CT
11:30-11:40
(2026-0142) Accelerometer-measured Chronoactivity and Osteoarthritis Risk: A Prospective Cohort Study
11:40-11:50
(2026-0397) Digital Pain Sentinel for Forecasting Fibromyalgia Pain Surges Using Causal Machine Learning Linking Air Pollution Shocks and Weather Volatility in Asia-Pacific Metropolises
- May 15 (Fri)
- 12:00-13:00
- Luncheon Symposium 5 [Eisai Korea Inc.]
- The Difference among JAK-Inhibitors
- Room 2 (3F)
- ENG
- Chair
- Yong-wook Park (Chonnam Nat'l Univ., Korea)
12:00-13:00
Balancing Efficacy and Safety: Real-World Experience and Clinical Benefits of Filgotinib
- May 15 (Fri)
- 13:00-14:30
- Free Paper Session 6_Rheumatoid Arthritis (I)
- Room 2 (3F)
- ENG
- Chairs
- Jungsik Song (Yonsei Univ., Korea)
- Hae-Rim Kim (Konkuk Univ., Korea)
13:00-13:10
(2026-0301) Circular RNA Profile Identifies CircSTRN and CircIRAK3 as Potential Biomarkers of Systemic Juvenile Idiopathic Arthritis
13:10-13:20
(2026-0081) Long Non-coding RNA NR_030732 Drives Pathogenic Fibroblast-like Synoviocyte Phenotypes and Osteoclast Differentiation in Rheumatoid Arthritis
13:20-13:30
(2026-0163) Therapeutic Efficacy of HzVSF-V13, a Vimentin-targeting Monoclonal Antibody, in Attenuating Rheumatoid Arthritis via Suppression of Th17 Cells and Osteoclastogenesis
13:30-13:40
(2026-0146) Changes in Erosion Volume and Functional Outcomes in Early Rheumatoid Arthritis: A Two-year Prospective HR-pQCT Study
13:40-13:50
(2026-0450) Clinical-ultrasonographic Discordance in Rheumatoid Arthritis: A Comparative Analysis of Biologic and Targeted Synthetic DMARDs
13:50-14:00
(2026-0149) Comparison of Clinical Characteristics and Drug Survivals of Biologic/targeted Synthetic DMARDs between Elderly and Non-elderly D2T-RA Patients: Data from KOBIO Registry
14:00-14:10
(2026-0099) DAS28-guided Treatment De-escalation and Risk of Disease Flare in Rheumatoid Arthritis: A Nationwide Registry Study
14:10-14:20
(2026-0101) Threshold Dose of Oral Glucocorticoid Therapy on Risk of Serious Infection in Patients with Rheumatoid Arthritis: A Nested Case–control Analysis
14:20-14:30
(2026-0041) Effect of Methotrexate Discontinuation on Immunogenicity of Recombinant Zoster Vaccine in Patients with Rheumatoid Arthritis
- May 15 (Fri)
- 15:30-17:00
- Free Paper Session 7_Spondyloarthritis Including Psoriatic Arthritis (I)
- Room 2 (3F)
- ENG
- Chairs
- Seong Ryul Kwon (Inha Univ., Korea)
- Min-Chan Park (Yonsei Univ., Korea)
15:30-15:40
(2026-0052) Dynamics of Interleukin-23/Interleukin-17 Axis and Type 1 Regulatory T Cells across Disease Stages in Axial Spondyloarthritis
15:40-15:50
(2026-0324) Deep Learning for Assessment of Disease Activity in Patients with Axial Spondyloarthritis Using Combined Sacrum and Spine MRI
15:50-16:00
(2026-0198) Development and Validation of the Modified Bath Ankylosing Spondylitis Metrology Index: A Mobile Artificial Intelligence Tool to Measure Spinal Mobility in Axial Spondyloarthropathy
16:00-16:10
(2026-0346) ADSC Secretome Exerts Anti-inflammatory Effect in the M5-induced HaCaT Keratinocytes and Murine Model of Psoriasis
16:10-16:20
(2026-0247) Novel Serum Biomarkers for Early Prediction of Structure Bone Damage in Psoriatic Arthritis
16:20-16:30
(2026-0147) Plasma Glutamate Levels in Treatment-naïve Psoriatic Arthritis Patients and the Correlation with Disease Activity
16:30-16:40
(2026-0262) Interpretable Machine Learning Identifies Refractory Inflammatory Immune States in Psoriatic Arthritis and Guides Precision Biologic and JAK Inhibitor Switching
16:40-16:50
(2026-0363) Gender-related Differences in Clinical Phenotypes and Musculoskeletal Ultrasound Findings among Chinese Patients with Psoriatic Arthritis
16:50-17:00
(2026-0159) Bridging the Gap: A Single Intramuscular Glucocorticoid Injection Provides Rapid and Sustained Benefit in Selected Active Psoriatic Arthritis with a Favorable Safety Profile
- May 15 (Fri)
- 08:00-09:00
- Breakfast Symposium 3 [Celltrion]
- Tocilizumab Biosimilar for Rheumatoid Arthritis
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- Jinseok Kim (Jeju Nat'l Univ., Korea)
08:00-09:00
Demonstrating Efficacy and Safety Equivalence of Avtozma: Results from Phase III Clinical Trial
- May 15 (Fri)
- 10:30-12:00
- KCR-KSBMR Joint Symposium_Clinical Osteoimmunology in Practice
- Room 3 (5F)
- ENG
- Chairs
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- Je-Yong Choi (Kyungpook Nat'l Univ., Korea)
10:30-11:00
Immune Cells and Bone Interaction
11:00-11:30
Cellular Crosstalk in Bone: A Therapeutic Perspective
11:30-12:00
Restoration of BMD by Treatment of Rheumatic Diseases
- May 15 (Fri)
- 12:00-13:00
- Luncheon Symposium 6 [Novartis]
- Bending the AS Curve Early with IL-17A Inhibition
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- Sung Won Lee (Dong-A Univ., Korea)
12:00-13:00
From Early Control to Sustained Outcomes with Secukinumab in AS
- May 15 (Fri)
- 13:00-14:30
- KCR-KCPCI Joint Symposium
- Room 3 (5F)
- ENG
- Chairs
- Youngdae Kim (Inje Univ., Korea)
- Myeungsu Lee (Wonkwang Univ., Korea)
13:00-13:30
Transition Care in Japan
13:30-14:00
Caring for Childhood-Onset SLE in Adult Rheumatology Care
14:00-14:30
Still's Disease across the Age Spectrum: Integrating Recent EULAR/PReS Recommendations
- May 15 (Fri)
- 15:30-17:00
- Health Insurance Committee Session
- Room 3 (5F)
- KOR (ENG Translation)
- Chairs
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- Chong-Hyeon Yoon (The Catholic Univ. of Korea, Korea)
15:30-16:00
Rheumatology Workforce Projections
16:00-16:30
Strategic Responses to Ensure the Supply of Rheumatologists
16:30-17:00
Panel Discussion
Youngsik Bang (Division of Health Personnel Policy, Ministry of Health and Welfare, Korea)
Sukil Kim (The Catholic Univ. of Korea, Korea)
Seung-Jae Hong (Kyung Hee Univ., Korea)
Bo Young Yoon (Inje Univ., Korea)
- May 15 (Fri)
- 14:30-15:30
- Poster Viewing & Tour 2
- Poster Zone (5F)
- ENG
- May 16 (Sat)
- 08:00-09:00
- Breakfast Symposium 4 [Eisai Korea Inc.]
- Personalized Treatment for RA
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Sang-Heon Lee (Konkuk Univ., Korea)
08:00-09:00
Identifying Right Patients for JAKi Therapy in RA
- May 16 (Sat)
- 09:00-10:00
- Keynote Lecture 2
- Room 1 (3F)
- ENG
- Chair
- Chang Keun Lee (Univ. of Ulsan, Korea)
09:00-10:00
Immune Checkpoint Receptors in Autoimmune Diseases
- May 16 (Sat)
- 10:30-12:00
- International Symposium 4 (KCR-JCR Research Committee)_Translating Genetic Epidemiology into Clinical Rheumatology
- Room 1 (3F)
- ENG
- Chairs
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
10:30-11:00
Mapping Genetic Architecture of Autoimmune Rheumatic Diseases: From GWAS Discoveries to Mechanistic Insights
11:00-11:30
Genetic Epidemiology in Clinical Rheumatology: Cohort-Based Insights from Korea
11:30-11:50
Panel Discussion_Future Collaboration between KCR and JCR in the Field of Clinical Research
Yoshiya Tanaka (Univ. of Occupational and Environmental Health, Japan)
Sang-Cheol Bae (Hanyang Univ., Korea)
11:50-12:00
KCR–JCR Clinical Research Committee MOU Signing Ceremony
- May 16 (Sat)
- 12:00-13:00
- Luncheon Symposium 7 [Johnson&Johnson]
- SIMPONI IV Efficacy in RA
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Jaejoon Lee (Sungkyunkwan Univ., Korea)
12:00-13:00
Rapid Onset Impact of Biologic from the Start: Golimumab IV in RA Treatment
- May 16 (Sat)
- 13:00-15:00
- Medical Humanities Session
- Room 1 (3F)
- KOR (ENG Translation)
- Chairs
- Sang-il Lee (Gyeongsang Nat'l Univ., Korea)
- Sang-Hyon Kim (Keimyung Univ., Korea)
13:00-14:00
Based on Medical Ethics, Physician-Patient Relationship in the Age of Medical Artificial Intelligence
14:00-15:00
Based on Medical Ethics, Physicians' Social Media Use and Social Trust
- May 16 (Sat)
- 08:00-09:00
- Breakfast Symposium 5 [Daewoong]
- The Expanding Therapeutic Spectrum in Rheumatic Diseases
- Room 2 (3F)
- KOR (ENG Translation)
- Chair
- Young Mo Kang (Kyungpook Nat'l Univ., Korea)
08:00-09:00
Clinical and Economic Value of Biosimilars across Therapeutic Areas: Evidence from Adalimumab and Denosumab Biosimilars (Xelenka® and Stoboclo®)
- May 16 (Sat)
- 10:30-12:00
- Free Paper Session 8_Rheumatoid Arthritis (II)
- Room 2 (3F)
- ENG
- Chairs
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- Eon Jeong Nam (Kyungpook Nat'l Univ., Korea)
10:30-10:40
(2026-0409) Pediatric JIA Biologic Dosing Fairness Index Integrating Weight Band Thresholds Trough Biologic Levels Syringe Dead Space Wastage and Insurance Tier Inequities across Global Health Systems in Routine Care
10:40-10:50
(2026-0281) Construction and Evaluation of a Chronic Arthritis Animal Model Induced by Persistent Activation of Toll-like Receptors via Lipopolysaccharide Stimulation
10:50-11:00
(2026-0254) Mathematical Modeling of a Synovial Response Digital Twin Identifies Nonresponse Bifurcation Thresholds to Tumor Necrosis Factor Inhibition in Rheumatoid Arthritis
11:00-11:10
(2026-0365) Role of Joint Space Analysis by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Predicting Inflammatory Arthritis among Patients with Arthralgia
11:10-11:20
(2026-0314) Tofacitinib and Upadacitinib Attenuate Lung Fibrosis by Modulating JAK/STAT and TGF-β/SMAD3 Signaling Crosstalk: Implications for the Management of Rheumatoid Arthritis-associated Interstitial Lung Disease
11:20-11:30
2026-0366 Impact of Baseline HDL-cholesterol and Early Treatment Patterns on the Risk Of Interstitial Lung Disease in Rheumatoid Arthritis: A Nationwide Multicenter CDM-based Cohort Study over 20 Years
11:30-11:40
(2026-0367) Cardiovascular Risk Stratification in Rheumatoid Arthritis Integrating Systemic Inflammatory Markers and Treatment Patterns: A Nationwide Multicenter CDM-based Study with Over 20 Years of Longitudinal Follow-up
11:40-11:50
(2026-0398) Distinct Disease Activity Trajectories with BDMARDs and TsDMARDs in Rheumatoid Arthritis: Insights from the BITORA Prospective Study
11:50-12:00
(2026-0260) Winning the Patient’s Perspective: A Head-to-head Meta-analysis of Upadacitinib versus Adalimumab on Pain, Physical Function, and Quality of Life in Rheumatoid Arthritis
- May 16 (Sat)
- 12:00-13:00
- Luncheon Symposium 8 [Amgen & ChongKunDang]
- Optimizing Osteoporosis Care for Rheumatology Patients
- Room 2 (3F)
- KOR (ENG Translation)
- Chair
- Yun Jong Lee (Seoul Nat'l Univ., Korea)
12:00-13:00
Why Prolia? Facts About Biologics and Biosimilars
- May 16 (Sat)
- 13:30-15:00
- Free Paper Session 9_Crystal Arthropathies and Miscellaneous Inflammatory Diseases
- Room 2 (3F)
- ENG
- Chairs
- Chan Hong Jeon (Soonchunhyang Univ., Korea)
- Joong Kyong Ahn (Sungkyunkwan Univ., Korea)
13:30-13:40
(2026-0158) Exosomal MiR-1290 from Adult-onset Still’s Disease Patients Drives Macrophage-mediated Inflammation
13:40-13:50
(2026-0071) Delineation of Pathogenic IgG4-secreting Cellular Networks in IgG4-related Disease by Spatial Transcriptomic and Proteomic Profiling
13:50-14:00
(2026-0283) A Multivariate Genomic Framework Reveals Shared Autoimmune Risk and Immunoregulatory Circuits in Macrophage Activation Syndrome: From Five Independent Clinical Centers
14:00-14:10
(2026-0076) Feasibility of Catheterization-free Approach in Idiopathic Retroperitoneal Fibrosis Patients Complicated with Hydronephrosis
14:10-14:20
(2026-0100) Comprehensive Extractable Nuclear Antigen Profiling for Predicting Immune Checkpoint Inhibitor–induced Rheumatic Immune-related Adverse Events
14:20-14:30
(2026-0375) A Comprehensive Analysis of the Transcriptional Expression Profile and Functional Role of Lactylation-related Genes in Gouty Arthritis
14:30-14:40
(2026-0215) The Impact of Temperature Variations on the Risk of Gout Flare: A Time-stratified Case-crossover Study
14:40-14:50
(2026-0173) Associations of Physical Activity Pattern with Incident Gout in a Prospective Cohort Study from UK Biobank
14:50-15:00
(2026-0303) AI-derived Coronary Plaque Phenotyping to Quantify Anti-inflammatory Treatment Response in Gout
- May 16 (Sat)
- 08:00-09:00
- Breakfast Symposium 6 [Abbvie]
- Exploring Disease Control Strategies of JAK inhibitor for Axial Spondyloarthritis
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- YoungIl Seo (Hallym Univ., Korea)
08:00-09:00
Optimizing Treatment across Diverse Patient Profiles in Axial Spondyloarthritis with Upadacitinib
- May 16 (Sat)
- 10:30-12:00
- Free Paper Session 10_Spondyloarthritis Including Psoriatic Arthritis (II)
- Room 3 (5F)
- ENG
- Chairs
- Sang-Hoon Lee (Kyung Hee Univ., Korea)
- Seonghoon Park (Daegu Catholic Univ., Korea)
10:30-10:40
(2026-0168) NSD1, H3K36me1/2 Methyltransferase as a Potential Therapeutic Target in Th17 Cell-mediated Autoinflammatory Disease
10:40-10:50
(2026-0465) Associations of RPS10 and DEF6 Polymorphisms with Radiographic Axial Spondyloarthritis in the Korean Population: A Genome-wide Association Study
10:50-11:00
(2026-0271) Epigenetic Landscape of Osteoprogenitors in Ankylosing Spondylitis: FOXF2 Methylation as a Key Determinant of Pathological Bone Formation
11:00-11:10
(2026-0357) Low TREX1 Levels Dysregulate Cigarette Smoke–mediated Osteoclastogenesis in Ankylosing Spondylitis
11:10-11:20
(2026-0145) The Oral-Gut Microbiome Axis in a Korean Cohort with Ankylosing Spondylitis: Initial Analysis from the INTEGRATE Cohort Study
11:20-11:30
(2026-0315) Salivary Microbiome Profiles across Disease Activity in Radiographic Axial Spondyloarthritis
11:30-11:40
(2026-0288) Impact of Diagnostic Delay on Long-term Radiographic Structural Outcomes in TNF Inhibitor–treated Radiographic Axial Spondyloarthritis
11:40-11:50
(2026-0119) Predictors of Treatment Response to IL-17 Inhibitors in Patients with Axial Spondyloarthritis: A Multicenter Real-world Longitudinal Study
11:50-12:00
(2026-0310) Comparison of the Risk of Acute Anterior Uveitis Flare between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial
- May 16 (Sat)
- 12:00-13:00
- Luncheon Symposium 9 [JW Pharmaceutical]
- Targeted Therapies in Systemic Vasculitis
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- Gunwoo Kim (Daegu Fatima Hosp., Korea)
12:00-13:00
The Role of IL-6 Pathway Blockade: Clinical Outcome of Tocilizumab Therapy in GCA
- May 16 (Sat)
- 13:30-15:00
- Free Paper Session 11_Epidemiology & Public Health
- Room 3 (5F)
- ENG
- Chairs
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- Soo-Kyung Cho (Hanyang Univ., Korea)
13:30-13:40
(2026-0140) Risk Factors for Cytomegalovirus Reactivation in Patients Receiving Prolonged High-dose Corticosteroids for Rheumatic Diseases: A Retrospective Cohort Study
13:40-13:50
(2026-0154) Real-world Incidence of Immune-related Adverse Events and Survival with Immune Checkpoint Inhibitors in Rheumatoid Arthritis Patients: A Nationwide Matched Cohort Study with Cancer Subgroup Analyses
13:50-14:00
(2026-0220) Risk Factors Associated with Major Cardiovascular Adverse Event and Heart Failure in Patients with Ankylosing Spondylitis: A Nationwide Nested Case-control Study
14:00-14:10
(2026-0460) Real-world Effectiveness of Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients Initiating Janus Kinase Inhibitors: A Single-center Korean Cohort Study
14:10-14:20
(2026-0047) Increased Risk of Cancer in Patients with Mixed Connective Tissue Disease: A Population-based Cohort Study in Korea
14:20-14:30
(2026-0361) Early-onset Gout and Risk of Genitourinary Cancers: A Nationwide Cohort Study of 6.5 million Young Adults
14:30-14:40
(2026-0019) Risk of Cognitive Disorders in Patients with Primary Sjögren Syndrome: Data from Korean Health Insurance Service
14:40-14:50
(2026-0224) Sex Differences in Medication Utilization and Healthcare Costs among Patients with Radiographic Axial Spondyloarthritis: A Nationwide Claims Database Study
14:50-15:00
(2026-0445) Infection-related Hospitalization, Treatment Persistence, and Mortality in Patients with Rheumatoid Arthritis Initiating Biologic or Targeted Synthetic DMARDs According to Residential Region and Treating Hospital Location: A Nationwide Cohort Study
- May 16 (Sat)
- 10:00-10:30
- Poster Viewing & Tour 3
- Poster Zone (5F)
- ENG
- May 16 (Sat)
- 13:00-13:30
- Poster Viewing
- Poster Zone (5F)
